EPO Patents = 3

Average Co-Inventor Count = 4.5

ph-index = 7

Forward Citations = 227(Granted Patents)

Location History:

Hofheim, Taunus, DE (1976)
Niederjosbach, Taunus, DE (1976 - 1978)
Niederjosbach, DE (1979 - 1980)
Eppstein, DE (1981 - 1987)
Brunswick, DE (1998)
Braunschweig, DE (1998 - 2010)
Frankfurt-am-Main, DE (1993 - 2012)

Company Filing History:

18 out of 6,662

Hoechst Aktiengesellschaft

patents

11 out of 330

Aventis Pharma Deutschland, Gmbh

patents

4 out of 1,827

Sanofi-a Ventis Deutschland Gmbh

Years Active: 1976-2012

Loading Chart...

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8143242 - Malonamide derivatives with antithrombotic activity (2012-03-27),

2. 7772270 - Imino acid derivatives as inhibitors of matrix metalloproteinases (2010-08-10),

3. 7741491 - Diphenylamine-substituted salicylthiazole derivatives and related compounds as phosphotyrosine phosphatase 1B (PTB1B) inhibitors for using as blood-sugar decreasing active ingredients for treating diabetes (2010-06-22),

4. 7453000 - Substituted oxazolobenzoisothiazole dioxide derivatives method for production and use thereof (2008-11-18),

5. 7166609 - Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases (2007-01-23),

6. 6933298 - Pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides and the use thereof for selectively inhibiting collagenases (2005-08-23),

7. 6897198 - Method of treatment with combinations of statin and aryl-substituted propanolamine derivatives (2005-05-24),

8. 6716853 - Cyclic N-substituted alpha-imino carboxylic acids for selective inhibition of collogenase (2004-04-06),

9. 6632838 - Use of bissulfonamides for producing medicines for the treatment of hyperlipidemia (2003-10-14),

10. 6596728 - Substituted 1,3-diaryl-2-pyrid-2-yl-3-(pyrid-2-ylamino)propanol derivatives, process for their preparation, pharmaceuticals comprising these compounds and their use (2003-07-22),

11. 6569835 - Combinations with statin and aryl-substituted propanolamine derivatives, their preparation pharmaceuticals comprising them, and their use (2003-05-27),

12. 6566340 - Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use (2003-05-20),

13. 6552048 - Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals (2003-04-22),

14. 6342512 - Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals (2002-01-29),

15. 6303639 - Propanolamine derivatives substituted by heterocyclic radicals, processes for their preparation, pharmaceuticals comprising these compounds and their use (2001-10-16),

Title: Reinhard Kirsch: Pioneering Innovations in Pharmaceuticals

Introduction:

Reinhard Kirsch, a distinguished inventor hailing from Braunschweig, DE, has left an indelible mark in the field of pharmaceuticals with his groundbreaking inventions and relentless pursuit of scientific advancement. With an impressive portfolio of 33 patents to his name, Reinhard Kirsch has revolutionized the landscape of antithrombotic and matrix metalloproteinase inhibitor compounds.

Latest Patents:

Among his latest patents is the development of Malonamide derivatives with potent antithrombotic activity. These compounds, characterized by their formula I structure, have shown remarkable efficacy in the treatment and prevention of cardiovascular disorders such as thromboembolic diseases and restenoses. Additionally, Reinhard Kirsch's invention of imino acid derivatives as inhibitors of matrix metalloproteinases underscores his commitment to addressing critical medical needs through innovative pharmaceutical solutions.

Career Highlights:

Reinhard Kirsch has contributed his profound expertise to renowned companies in the pharmaceutical industry, including Hoechst Aktiengesellschaft and Aventis Pharma Deutschland, GmbH. His tenure at these esteemed institutions has been marked by a relentless dedication to scientific excellence and a passion for pushing the boundaries of pharmaceutical innovation.

Collaborations:

Throughout his illustrious career, Reinhard Kirsch has collaborated closely with esteemed colleagues such as Dieter Duwel and Heinz Loewe. Together, they have synergized their collective insights and expertise to drive forward groundbreaking research initiatives and forge new pathways in pharmaceutical development.

Conclusion:

In conclusion, Reinhard Kirsch stands as a luminary in the realm of pharmaceutical innovations, with a prolific track record of patents that have transformed the landscape of medical treatments. His unwavering commitment to scientific advancement and his collaborative spirit exemplify the essence of a true visionary in the field of inventors. Reinhard Kirsch's contributions continue to inspire future generations of inventors and researchers to push the boundaries of what is possible in the realm of pharmaceutical sciences.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

3 patents (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.